| 11.04.2023 08:57 | AZN | TOP NEWS: Sanofi wins US drug control from AstraZeneca in Sobi deal | Alliance |
| 11.04.2023 07:00 | AZN | Update to arrangements with Sobi and Sanofi | RNS |
| 06.04.2023 07:55 | AZN | TOP NEWS: AstraZeneca's cancer drug Lynparza approved by NHS England | Alliance |
| 05.04.2023 09:13 | AZN | AstraZeneca receives positive interim trial results for Imfinzi drug | Alliance |
| 05.04.2023 07:00 | AZN | Lynparza + Imfinzi met endpoint in ovarian cancer | RNS |
| 03.04.2023 15:00 | AZN | Total Voting Rights | RNS |
| 03.04.2023 08:45 | AZN | TOP NEWS: AstraZeneca's ultomiris recommended for EU approval | Alliance |
| 03.04.2023 07:00 | AZN | Ultomiris recommended for NMOSD EU approval | RNS |
| 30.03.2023 09:27 | AZN | AstraZeneca signs exclusive global license deal with KYM Biosciences | Alliance |
| 30.03.2023 07:00 | AZN | AstraZeneca completes KYM agreement for CMG901 | RNS |
| 27.03.2023 11:00 | AZN | Director/PDMR Shareholding | RNS |
| 27.03.2023 08:52 | AZN | TOP NEWS: AstraZeneca hails eplontersen; Enhertu wins another approval | Alliance |
| 23.03.2023 08:58 | AZN | TOP NEWS: AstraZeneca's Calquence receives first approval in China | Alliance |
| 22.03.2023 11:00 | AZN | Notice of AGM | RNS |
| 20.03.2023 15:50 | SHEL, MTVW, AZN | UK dividends calendar - next 7 days | Alliance |
| 15.03.2023 09:36 | JSG, IQE, GEN | LONDON BROKER RATINGS: Jefferies rates Future at 'hold'; Spirent upped | Alliance |
| 09.03.2023 10:34 | AZN | AstraZeneca hails trial results of cancer drugs Imfinzi and Tagrisso | Alliance |
| 09.03.2023 07:00 | AZN | Imfinzi improved EFS in resectable lung cancer | RNS |
| 08.03.2023 11:01 | AZN | Director/PDMR Shareholding | RNS |
| 08.03.2023 11:00 | AZN | Director/PDMR Shareholding | RNS |
| 06.03.2023 08:29 | AZN | TOP NEWS: AstraZeneca hails Enhertu phase 2 trial results | Alliance |
| 06.03.2023 07:00 | AZN | Enhertu DESTINY-PanTumor02 shows positive results | RNS |
| 02.03.2023 17:20 | AZN | US FDA to discuss AstraZeneca and Merck's Lynparza cancer drug combo | Alliance |
| 01.03.2023 19:38 | AZN | IN BRIEF: AstraZeneca prices three tranche global bond offering | Alliance |
| 01.03.2023 15:00 | AZN | Total Voting Rights | RNS |
| 01.03.2023 07:00 | AZN | AstraZeneca prices a $2.25bn bond offering | RNS |
| 24.02.2023 18:15 | AZN | AstraZeneca prices a EUR1.5bn bond offering | RNS |
| 24.02.2023 14:35 | AZN | TOP NEWS: AstraZeneca closes CinCor buy; Enhertu wins Chinese approval | Alliance |
| 24.02.2023 14:05 | AZN | AstraZeneca acquires CinCor for cardiorenal asset | RNS |
| 24.02.2023 11:00 | AZN | Director/PDMR Shareholding | RNS |
| 23.02.2023 09:01 | AZN | AstraZeneca signs USD63 million agreement to address gastric cancer | Alliance |
| 23.02.2023 07:00 | AZN | AstraZeneca enters agreement with KYM for CMG901 | RNS |
| 22.02.2023 09:11 | AZN | TOP NEWS: AstraZeneca wins three approvals in EU for cancer drugs | Alliance |
| 22.02.2023 07:10 | AZN | Filing of Form 20-F with SEC | RNS |
| 21.02.2023 11:00 | AZN | Annual Financial Report | RNS |
| 21.02.2023 10:17 | GBG, XPP, TTG | LONDON BROKER RATINGS: BoA cuts DS Smith; Jefferies likes JTC | Alliance |
| 21.02.2023 09:42 | AZN | AstraZeneca reports protection against RSV in infants with Beyfortus | Alliance |
| 16.02.2023 15:47 | WTAN, ULVR, SUPR | UK dividends calendar - next 7 days | Alliance |
| 15.02.2023 14:30 | AZN | AstraZeneca's Evusheld not recommended by NHS for vulnerable people | Alliance |
| 15.02.2023 09:32 | SXS, DOM, TRN | LONDON BROKER RATINGS: Bryan Garnier starts Unilever with 'neutral' | Alliance |
| 13.02.2023 14:01 | AZN | Director/PDMR Shareholding | RNS |
| 13.02.2023 14:00 | AZN | Director/PDMR Shareholding | RNS |
| 10.02.2023 10:32 | AZN | UPDATE: Hunt disappointed UK loses new AstraZeneca factory to Ireland | Alliance |
| 10.02.2023 10:27 | AZN | Hunt disappointed UK 'lost out this time' on new AstraZeneca factory | Alliance |
| 09.02.2023 08:42 | AZN | TOP NEWS: AstraZeneca swings to profit as Alexion adds to 2022 revenue | Alliance |
| 09.02.2023 07:00 | AZN | Final Results | RNS |
| 07.02.2023 08:23 | AZN | CORRECT: EU approves AstraZeneca's Forxiga for chronic heart failure | Alliance |
| 07.02.2023 08:05 | AZN | TOP NEWS: EU approves AstraZeneca's Forxiga for chronic heart failure | Alliance |
| 02.02.2023 15:49 | WOSG, ULVR, RDW | UK earnings, trading statements calendar - next 7 days | Alliance |
| 02.02.2023 14:50 | AZN | TOP NEWS: AstraZeneca's, Amgen's Tezspire pre-filled pen wins approval | Alliance |
| 01.02.2023 15:00 | AZN | Total Voting Rights | RNS |
| 30.01.2023 16:35 | AZN | Daiichi begins Tropion-Lung07 phase 3 trial for lung cancer treatment | Alliance |
| 26.01.2023 21:30 | AZN | IN BRIEF: AstraZeneca loses emergency use authorisation for Evusheld | Alliance |
| 26.01.2023 18:15 | AZN | Update on Evusheld US EUA | RNS |
| 26.01.2023 09:40 | AZN | TOP NEWS: AstraZeneca's Enhertu approved in EU for breast cancer form | Alliance |
| 25.01.2023 09:33 | CRE, NICL, S32 | LONDON BROKER RATINGS: Goldman likes UK banks; HSBC cuts Dr Martens | Alliance |
| 23.01.2023 09:41 | RSG, THS, PAF | LONDON BROKER RATINGS: Jefferies cuts Berkeley; HSBC cuts St James's | Alliance |
| 20.01.2023 09:25 | BHP, ROO, JET | LONDON BROKER RATINGS: Bank of America raises Asos, boohoo to 'buy' | Alliance |
| 19.01.2023 09:38 | FEVR, DFS, CRW | LONDON BROKER RATINGS: Goldman Sachs cuts Relx but raises WPP | Alliance |
| 18.01.2023 09:47 | THG, WISE, HTG | LONDON BROKER RATINGS: Bank of America and Oddo BHF cut Whitbread | Alliance |
| 16.01.2023 08:49 | AZN | TOP NEWS: AstraZeneca completes acquisition of Neogene Therapeutics | Alliance |
| 16.01.2023 07:00 | AZN | Acquisition of Neogene Therapeutics completed | RNS |
| 13.01.2023 09:08 | AZN | CORRECT: AstraZeneca asthma drug okayed in EU for self-administration | Alliance |
| 13.01.2023 08:29 | AZN | AstraZeneca asthma drug approved in US for self-administration | Alliance |
| 11.01.2023 14:05 | AZN | TOP NEWS: FDA approves AstraZeneca asthma drug Airsupra for adults | Alliance |
| 11.01.2023 13:00 | AZN | Airsupra (PT027) approved in US for asthma | RNS |
| 10.01.2023 15:10 | AZN | C4X Discovery promotes Nick Ray to chief scientific officer | Alliance |
| 09.01.2023 09:11 | AZN | TOP NEWS: AstraZeneca buys biotech CinCor for up to USD1.8 billion | Alliance |
| 09.01.2023 07:00 | AZN | AstraZeneca acquire CinCor for cardiorenal asset | RNS |
| 06.01.2023 09:22 | DAL, ROO, BOY | LONDON BROKER RATINGS: Credit Suisse cuts Next to 'underperform' | Alliance |
| 05.01.2023 09:20 | ITV, HSBA, VOD | LONDON BROKER RATINGS: Bank of America cuts Pearson to 'underperform' | Alliance |
| 05.01.2023 07:47 | AZN | TOP NEWS: AstraZeneca's and Sanofi's nirsevimab approved for US review | Alliance |
| 03.01.2023 15:00 | AZN | Total Voting Rights | RNS |
| 03.01.2023 09:24 | DRX, HIK, WIZZ | LONDON BROKER RATINGS: Citigroup cuts Wizz Air; Redburn likes CRH | Alliance |
| 30.12.2022 11:00 | AZN | Director/PDMR Shareholding | RNS |
